Weld Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
LPC
Weld Capital Management's MRNA Position: Q2 2021 in Review
Weld Capital Management sold out of Moderna (MRNA) in Q2 2021, closing a stake of 5,963 shares — an estimated $781K sold.
Weld Capital Management first reported a position in MRNA in Q1 2019 and held it in 2 quarters. The position peaked at $781K in Q1 2021. 904 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.
- Weld Capital Management reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
- Weld Capital Management sold 5,963 Moderna shares in Q2 2021, an estimated $781K.
- Weld Capital Management first reported a position in Moderna in Q1 2019 and held it in 2 quarters.
- Weld Capital Management's Moderna position peaked at $781K in Q1 2021.
- 904 funds tracked by Wall St. Rank held Moderna as of Q2 2021.
Based on Weld Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.